Our Expert Network

1. Enhancing Gene And Cell Therapies With Circular RNA-Based Gene Expression 6/29/2026

   While circular RNA platforms can enhance protein expression, developing effective delivery strategies remains the key challenge to achieving therapeutic efficacy.

2. Unlocking The Future Of mRNA 6/29/2026

   Many regulatory frameworks and analytical approaches were not originally designed for platforms like mRNA. Addressing these gaps will be essential to fully realize the potential of mRNA technologies.

3. The Missing Partners In microRNA Silencing: What QKI Reveals About RNA Regulatory Complexity 6/26/2026

   New research suggests microRNA silencing depends on RNA-binding protein partners like QKI, revealing a more complex regulatory network shaping gene expression.

4. The Hidden Bottleneck In Advanced Therapies Isn't Science… It's Translational Friction 6/26/2026

   Scientific breakthroughs may spark innovation, but operational excellence ultimately determines which advanced therapies reach patients.

5. RNA Therapeutics: Why CMC Strategy Will Define The Next Decade 6/25/2026

   As RNA matures into an industrial platform, long-term success will depend less on discovery and more on scalable CMC systems, integration, and execution.

6. Rethinking The Oligonucleotide Backbone: Why RNA Therapeutics May Need A New Molecular Design Framework 6/24/2026

   New backbone chemistries could unlock greater control over delivery, specificity, and safety, expanding the molecular design space for RNA medicines.

7. RNA Platforms: What Transfers And What Breaks 6/23/2026

   A practical framework for distinguishing reusable RNA platform knowledge from biology-specific unknowns as therapeutics expand into new tissues and indications.

8. The Hidden Language Of RNA: How lncRNA-Splicing Networks Are Redefining The Future Of Therapeutics 6/19/2026

   Long non-coding RNAs and splicing networks are emerging as master regulators of cellular identity, opening new therapeutic opportunities beyond proteins.

9. RNA-Binding Proteins As Architects Of Post-Transcriptional Control In Disease Biology 6/18/2026

   RNA-binding proteins orchestrate splicing, stability, localization, and translation, emerging as powerful regulators and therapeutic targets in disease.

10. Structure-Guided siRNA Design: How Chemistry, Context, And Constraint Are Shaping The Next Phase Of RNAi Therapeutics 6/8/2026

    As siRNA design matures, the next breakthroughs will depend on balancing chemical optimization, delivery challenges, and expanding beyond established design rules.